Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.438.0324.0616.719.66

What is the latest EV/Core EBITDA ratio of TTK HEALTHCARE ?

The latest EV/Core EBITDA ratio of TTK HEALTHCARE is 13.43 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.43
Mar20238.03
Mar202224.06
Mar202116.71
Mar20209.66

How is EV/Core EBITDA of TTK HEALTHCARE Trending?

Years EV/Core EBITDA % Change
Mar2024 13.43
67.25
Mar2023 8.03
-66.63
Mar2022 24.06
43.99
Mar2021 16.71
72.98
Mar2020 9.66 -

Other Financial Ratios of TTK HEALTHCARE


Compare EV/Core EBITDA ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,739.7 Cr -1.3% 7.4% -22.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,725.0 Cr 2.5% 0.2% 17.2% Stock Analytics
DIVIS LABORATORIES ₹159,525.0 Cr 2.1% 3.7% 66.4% Stock Analytics
CIPLA ₹123,206.0 Cr 0.9% 0.1% 14.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,519.0 Cr -0.6% 0.4% 28.3% Stock Analytics
DR REDDYS LABORATORIES ₹97,927.5 Cr -0.3% -2.2% -0.1% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-1.3%

7.4%

-22.9%

SENSEX

0.8%

3.8%

8.4%


You may also like the below Video Courses